This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
When on the combo treatment Venetoclax (Venclexta) and obinutuzumab, is it recommended to avoid crowds, not travel, all things considered with COVID?
From Dr. Koffman
The data suggest that all CLL patients are at increased risk regardless of treatment. In addition, Venetoclax may lower neutrophils as might Obinutuzumab which will also kill off all your good and bad B cells, limiting your ability to make protective antibodies. These two drugs theoretically could increase your risk, but the risks are high already for CLL patients who get symptomatic COVID-19. I would avoid crowds and travel now.